SBH
CC icon

Segall Bryant & Hamill’s Chemours CC Stock Holding History

Segall Bryant & Hamill’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-4,204
Closed -$213K – 571
2017
Q3 		$213K Buy
+4,204
New +$198K ﹤0.01% 541
2015
Q4 		– Sell
-10,904
Closed -$71K – 533
2015
Q3 		$71K Buy
+10,904
New +$114K ﹤0.01% 535

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Segall Bryant & Hamill's CC Position: Q4 2017 in Review

Segall Bryant & Hamill sold out of Chemours (CC) in Q4 2017, closing a stake of 4,204 shares — an estimated $213K sold.

Segall Bryant & Hamill first reported a position in CC in Q3 2015 and held it in 2 quarters. The position peaked at $213K in Q3 2017. 537 funds tracked by Wall St. Rank hold CC as of Q4 2017.

  • Segall Bryant & Hamill reported no remaining Chemours position as of Q4 2017 after selling out during the quarter.
  • Segall Bryant & Hamill sold 4,204 Chemours shares in Q4 2017, an estimated $213K.
  • Segall Bryant & Hamill first reported a position in Chemours in Q3 2015 and held it in 2 quarters.
  • Segall Bryant & Hamill's Chemours position peaked at $213K in Q3 2017.
  • 537 funds tracked by Wall St. Rank held Chemours as of Q4 2017.

Based on Segall Bryant & Hamill's 13F filing for Q4 2017, filed 15 Feb 2018.